Source: Annual Congress 2003 - Cystic fibrosis: modern methods of monitoring the disease



Rating:

Share or cite this content

Citations should be made in the following way:
J. Naumenko, A. Cherniak, G. Nekludova, E. Amelina, A. G. Chuchalin (Moscow, Russia). Pulmonary hypertension as a predictor of survival in cystic fibrosis. Eur Respir J 2003; 22: Suppl. 45, 1540

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension in cystic fibrosis patients Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 47:1445-1451 Year: 2016 Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007 Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Source: Eur Respir J 2011; 37: 176-183 Year: 2011 Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Comparison of clinical characteristics and prognostic factors between combined pulmonary fibrosis and emphysema/UIP versus non-UIP Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir Mon 2012; 57: 148-160 Year: 2012 Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Never-smoking history as a poor prognostic factor in surgically proven idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and emphysema and associated pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008 A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 36: 1067-1072 Year: 2010 Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Idiopathic pulmonary upper lobe fibrosis shows distinct features and poor prognosis compared to idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Source: Eur Respir J 2007; 30: 715-721 Year: 2007 Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 40: 93-100 Year: 2012 Idiopathic pulmonary fibrosis: Relationship between patient survival and distance-saturation product Source: International Congress 2015 – IPF: clinical aspects Year: 2015